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Amyotrophic lateral sclerosisStriated skeletal muscle cells from humans represent a valuable source for in vitro studies of the motoric system
as well as for pathophysiological investigations in the clinical settings. Myoblasts can readily be grown from
human muscle tissue. However, if muscle tissue is unavailable, myogenic cells can be generated from human
induced pluripotent stem cells (hiPSCs) preferably without genetic engineering. Our study aimed to optimize
the generation of hiPSCs derived myogenic cells by employing selection of CD34 positive cells and followed by
distinct, stepwise culture conditions. Following the expansion of CD34 positive single cells under myogenic cell
culture conditions, serum deprived myoblast-like cells ﬁnally fused and formed multinucleated striated
myotubes that expressed a set of key markers for muscle differentiation. In addition, these myotubes contracted
upon electrical stimulation, responded to acetylcholine (Ach) andwere able to generate action potentials. Finally,
we co-cultured motoneurons and myotubes generated from identical hiPSCs cell lines. We could observe the
early aggregation of acetylcholine receptors inmuscle cells of immature co-cultures. At later stages, we identiﬁed
and characterisedmature neuromuscular junctions (NMJs). In summary, we describe here the successful gener-
ation of an iPS cell derived functional cellular system consisting of two distinct communicating cells types. This
in vitro co-culture system could therefore contribute to research on diseases in which the motoneurons and
the NMJ are predominantly affected, such as in amyotrophic lateral sclerosis or spinal muscular atrophy.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Motoneurons make contact with the skeletal muscle to form the
neuromuscular junction (NMJ), which is required for signal transmis-
sion. Disorders of the NMJ such asmyasthenia gravis lead to varying de-
grees of muscle weakness (Gomez et al., 2010). Muscle wasting and
weakness in motoneuron diseases arise predominantly from the loss
of motoneurons. Hence, research has focused on investigating the
mechanisms of motoneuron cell death (de Carvalho et al., 2014). In ad-
dition, there is growing evidence indicating that alterations of NMJs
and/or the skeletal muscle itself affect the pathogenic process inne receptor; ALS, amyotrophic
factor; BT, bungarotoxin; EB,
; FGF, ﬁbroblast growth factor;
derived growth factor; MEFS,
tion; PBS, phosphate buffered
ell Biology, Albert Einstein Allee
mestre),
. This is an open access article underamyotrophic lateral sclerosis (ALS) (Miller et al., 2006; Murray et al.,
2010; Wong and Martin, 2010).
In vitromodels could contribute to the analysis of the pathophysiol-
ogy of motoneuron diseases and might help to screen for therapeutic
options. Human induced pluripotent stem cell (hiPSC) technology has
opened new avenues for elucidating underlying pathomechanisms
and even putative treatment options. Cell culture systems generated
from patient speciﬁc somatic tissue harbour the genetic defects giving
the opportunity to analyse the functional impairment in vitro. Further-
more, the ability to repair underlying genemutations in patient speciﬁc
cells with modern gene editing systems provides the possibility of au-
tologous cell transplantations. Recently, different methods have been
published describing the generation of myoblasts from hiPSCs by intro-
ducing lentiviral systems forcingmyogenic differentiation (Darabi et al.,
2012; Goudenege et al., 2012; Tanaka et al., 2013; Abujarour et al.,
2014). In addition, a sphere based culture system to generate hiPSC
derived myoblast has recently been described but in these myogenic
cultures a high degree of neuronal contamination was observed
(Hosoyama et al., 2014). However, protocols giving rise to signiﬁcant
numbers of skeletal muscle cells without genetic engineering are there-
fore more physiological methods and are still in need to be developed.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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myogenic progenitors to enhance cell populations with myogenic
potential are membrane bound surface proteins of the large family of
CD factors, involved in a variety of cellular functions. One interesting
candidate marker to select for myogenic precursors is CD34, expressed
in quiescent satellite cells and proliferating myogenic precursors
(Beauchamp et al., 2000; Jankowski et al., 2002; Zammit et al., 2006).
Additionally, factors involved in promoting the myogenic potential of
stem cells are produced and secreted by muscle stem or progenitor
cells that in turn enhance in vitro differentiation of stem cells into the
myogenic lineage (Stern-Straeter et al., 2014).
We and others have shown that hiPSC have the ability to differenti-
ate into different cell types belonging to the motor system, especially to
lower motoneurons (Stockmann et al., 2011). In this context, a
co-culture system using hiPSC derived motoneurons and differentiated
primary myotubes represents the bona ﬁde model to investigate
motoneuron and muscle cell degeneration. This model system is able
to generate functional NMJs displaying all features of functional
connections (Stockmann et al., 2011). In another study, disease speciﬁc
motoneurons derived from a dystrophy type 1-hiPSC cell line were co-
culturedwithmyotubes generated froma ‘non-diseased’ humanmuscle
cell line,Mu2b3 (Marteyn et al., 2011). In the present study,we success-
fully established co-cultures for the ﬁrst time combining motoneurons
and myotubes generated from the same donor hiPSC cell line. In these
co-cultures, the aggregation of acetylcholine receptors (AchR)s and
the formation of intact NMJs could be detected. This in vitro culture
system can be used to further our understanding of the pathogenesis
of diseases in which NMJs are affected.2. Materials and methods
2.1. Generation of hiPSCs
Keratinocytes from plucked human (hiPSC1: female 40 years old,
hiPSC2: male 35 years old) hair were generated as described previously
(Linta et al., 2011; Stockmann et al., 2011; Illing et al., 2013).
Keratinocytes were grown on 20 μg/mL collagen IV-coated dishes and
cultured in EpiLife medium supplemented with HKGS (both Life tech-
nologies, USA). After reaching 75% conﬂuency keratinocytes were in-
fected on two consecutive days with proviral genome copies of a
lentivirus containing a polycistronic expression cassette encoding
OCT4, SOX2, KlF4, and cMYC (Sommer et al., 2009), diluted in EpiLifeme-
dium containing 8 μg/mL polybrene. Lentiviral particles were produced
as described previously (Linta et al., 2011).More details are described in
Supplemental methods. On the third day, keratinocytes were trans-
ferred onto irradiated rat embryonic ﬁbroblasts used as feeder cells,
which had been isolated from E14 Sprague Dawley rat embryos as de-
scribed previously (Linta et al., 2011) and previously cultured in
DMEM supplemented with 15% foetal bovine serum, 2 mM GlutaMAX,
100 mM non-essential amino acids and 1% Antibiotic–Antimycotic (all
from Life technologies). Keratinocytes growing on rat embryonic ﬁbro-
blasts were cultured in hiPSC medium consisting of knockout/DMEM
supplemented with 20% knockout serum replacement, 2 mM
GlutaMAX, 100 mM non-essential amino acids (all from Life technolo-
gies), 1% Antibiotic–Antimycotic, 100 mM β-mercaptoethanol
(Millipore, USA), 50 mg/mL vitamin C, and 10 ng/mL ﬁbroblast growth
factor-2 (FGF-2) (both from PeproTech, USA) in a 5% O2 incubator. Me-
dium was changed daily. After 3–5 days small colonies appeared with
typical hiPSCs morphology. Around 14 days later, hiPSC colonies had
the appropriate size for mechanical passaging and were transferred
onto irradiated mouse embryonic ﬁbroblasts (MEFs) (Stem Cell Tech-
nologies, France) and further cultivated with hiPSC medium. After one
passage hiPSC colonies were mechanically picked and transferred to
plates free of feeder cells and maintained with mTReSR1 medium
(Stem Cell Technologies). For splitting, hiPSCs colonies were incubatedwith dispase (StemCell Technologies) for 5–7 min at 37°C and subse-
quently detached using a cell scraper.2.2. Differentiation of hiPSC into myoblasts or motoneurons
HiPSCs were differentiated into myoblast in two ways (Fig. 1a, b).
First, we generated myoblast from hiPSC using differentiation towards
mesoderm and CD34+ selection. To favour mesoderm differentiation,
hiPSCs cultivated on mTReSR1 were expanded on MEFs feeder layers
and cultivated with hiPSCs medium supplemented with vitamin C and
FGF-2 as described above. To split cells dispase was used, but addition-
ally, in order to remove MEFs from the cultures detached cells were
incubated in ﬂasks for 2 h at 37 °C. During this time MEFs attached
gradually onto the bottom of the ﬂask and hiPSC cells remained in
solution. Afterwards, cells remaining in solution were transferred into
non-adherent ﬂasks to generate embryoid bodies (EBs). EBs were
grown in hiPSC medium for 2 days with 10 μM Rock-inhibitor
Y-276342 (Ascent, UK) for the ﬁrst 24 h. Then, medium was replaced
to myogenic medium containing 15% horse serum, 10% foetal bovine
serum (both from Life technologies), 10% chicken embryo extract
(Biomol, Germany), 100 μM β-mercaptoethanol (Millipore), 1% Antibi-
otic–Antimycotic, for 14 days. Afterwards, EBs were carefully attached
on laminin (25 μg/mL, Roche, Switzerland) coated plates and grown
for 2 weeks with one half of myogenic medium supplemented with
vitamin C (50 μg/mL) and FGF-2 (2 ng/mL) and the other half with
conditioned medium generated from the cultivation of human primary
myoblasts (described below).
To avoid the contamination of human primary myoblasts into our
cultures the medium obtained from human primary myoblast cultures
was centrifuged, ﬁltered through a 30 μm ﬁlter and stored at−20 °C.
To select speciﬁc CD34 positive cells by cell sorting, cells were digested
with Accutase (Stem Cell Technologies) for 5 min at 37 °C andmechan-
ically dissociated with a ﬁre-polished glass pipette. Afterwards the cell
suspensionwas passed through a 70 μm ﬁlter to remove cell aggregates.
Cells were re-suspended in phosphate buffered saline (PBS) containing
0.5% bovine serum albumin and 2 mM EDTA. Cells were labelled with
anti-CD34 microbeads using Miltenyi Biotec kits following the
manufacturer's instructions. Magnetic separation was carried out with
MACS separation columns (Miltenyi Biotec, Germany). Positive and
negative fractions were eluted three times to increase the purity of the
samples.
CD34 positive cells were then plated on laminin coated plates and
fed with myogenic medium supplemented with FGF-2 and vitamin C
and conditioned medium generated from human primary myoblasts
cultures, for 2 weeks. Cells were split using TrypLE (Life technologies).
To enrich myogenic cells the pre-plating method described by Park
and collaborators (Park et al., 2006) with some modiﬁcations was
used. Brieﬂy, cells were detached and then pre-plated in a gelatin-
coated ﬂask. After 45 min of incubation, mainly ﬁbroblasts are known
to adhere. The supernatant containing the non-attached cells was
collected and re-plated into a fresh gelatine coated ﬂask. After 2 serial
platings, the culture was enriched with small, round myogenic cells.
To generate speciﬁcmyogenic clones after onepassage cellswere sorted
by size using live cell-FACS analysis (Beckton Dickinson/FACSARIA III).
Only small cells, as assessed by forward scatter size, were sorted and
plated as single cells. Subsequently single cloneswere further expanded
in conditioned myogenic medium.
Second, the generation of hiPSC-derived myoblasts by PAX7 over
expression was done as previously described by Darabi and colleagues
(Darabi et al., 2012; Skoglund et al., 2014). Details are described in
supplemental methods.
HiPSCs were differentiated into motoneurons essentially as
previously described (Hu and Zhang, 2009) with some modiﬁcations
and extensively characterised as outlined elsewhere (Stockmann et al.,
2011).
Fig. 1. A–C. Schematic diagram describing the 3 methods used to generate myoblasts A. CD34+ selectedmyoblasts derived from hiPSC. B. hiPSC derived myoblasts by PAX7 induction. C.
Myoblast isolation from human skeletal muscle biopsies.
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Primary skeletal muscle stem cells were isolated from a M. vastus
lateralis muscle biopsy as described (Orth et al., 2003; Park et al.,
2006) (Fig. 1c). Cells were expanded inmyogenicmedium supplement-
ed with vitamin C and FGF-2 as described above. For passaging, human
myoblasts were plated on gelatine coated ﬂasks at a density of 25 cells
per mm2 in myogenic medium. Cultures were fed every 2 days by
changing the whole medium. When cells were 60% conﬂuent, medium
was replaced to a commercial medium for 24 h (SKGM, Lonza Inc.,
USA) before differentiation.2.4. Myotube motoneuron co-culture
Myoblasts generated from all three methods were differentiated
into myotubes by changing the medium to DMEM supplemented with
10 μg/mL insulin (SigmaAldrich, Germany), 500 μg/mL bovine serumal-
bumin (Life technologies;) and 10 ng/mL epidermal growth factor
(Prepotech). Cells were fed every 2 days by exchanging half of the
medium.
To generate primary motoneurons, time-mated adult pregnant
Sprague–Dawley rats at E14 were anaesthetized and sacriﬁced by CO2
overdose, the embryos were removed from the uterus, brains/spinal
cords were dissected out and placed into ice-cold Hank's balanced salt
solution (HBSS) supplemented with 1% Antibiotic–Antimytotic and 1%
glucose (Sigma Aldrich).
Primary spinal cord cultures were established adapting previously
published methods (Martinou et al., 1989; Stockmann et al., 2013).For co-culture experiments rat primary motoneurons were plated on
top of differentiated myotubes at a density of 10 × 104 cells per well
in neuronal medium containing 32% DMEM-high glucose, 62%
knockout-DMEM/F12, 1% glutamate, 2% B27 supplement (Life technolo-
gies), 1% Antibiotic–Antimycotic, 2% knockout-serum replacement and
1% non-essential amino acids. Cells were cultured in a humidiﬁed
incubator at 37 °C and 5% CO2 for two weeks.
For co-culture experiments with hiPCS-derived motoneurons,
motoneuron-enriched neurospheres (after 14 days of pumorphamine
(50 ng/mL, R&D Systems, USA)-treatment) were seeded onto hiPSC-
differentiatedmyotubes and cultured in DMEM/F12-Glutamaxmedium
supplemented with 1:50 hormonemix (1,2 μM sodium selenite, 0,8 μM
progesterone, 4 mg/mL apotransferrin, 1 mg/mL insulin and 386 μg/mL
putrescin (all from Sigma)) together with brain derived neurotrophic
factor (BDNF), glial derived neurotrophic factor (GDNF), insulin growth
factor (IGF)-1 (all 10 ng/mL, Prepotech) in the presence of 2% B-27, 2%
knockout serum replacement and 1% Antibiotic–Antimycotic.
Co-cultures were kept in culture for up to 3–4 weeks.
2.5. Immunocytochemistry and α-bungarotoxin labelling
For immunocytochemistry and labelling of AchRwithα-bungarotoxin
(BT) previously established methods were used (Demestre et al., 2005).
The primary antibodies used were: mouse anti human actinin (Sigma
Aldrich, 1:200), mouse anti-human desmin (DAKO, Denmark, 1:500),
rabbit anti-human myosin heavy chain (MHC) (abcam, UK, 1:500), goat
anti-humanAChR (Serotec, Germany, 1:500)mouse anti-human Bassoon
(Synaptic System, Germany, 1:1000). Fluorescence labelled secondary
antibodies were: Alexa Fluor® 488, Alexa Fluor® 568, and Alexa Fluor®
331M. Demestre et al. / Stem Cell Research 15 (2015) 328–336647 (from Life technologies) diluted 1:1000. Conjugatedα-BT-488 or 568
(Life technologies) was used at 5 ng/mL.
2.6. Quantitative one-step real time PCR
RT-PCR (qPCR) analysis was performed as previously described
(Stockmann et al., 2011) Brieﬂy, one-step real-time qPCR was carried
out using the Rotor-Gene Q (Qiagen, Germany) and the QuantiTect
SYBR Green RT-PCR kit (Qiagen). Primers for PAX3, PAX7,MYF5,MYH6,
MYOD1,MYOGENIN,DESMIN, and CHRNA1were purchased fromQiagen
as validated primers without sequence information (www.qiagen.
com). Relative transcript expressionwas expressed as the ratio of target
gene concentration to the housekeeping gene hydroxymethylbilane
synthase from Qiagen (Illing et al., 2013).
2.7. Electrophysiology of myotubes
Electrophysiological experiments were performed as previously de-
scribed (Stockmann et al., 2011). In brief, hiPSC derived myotubes and
myotubes from a biopsy from a healthy donor were differentiated
with Neurobasal A medium (Life technologies) supplemented with G5
(1×, Life technologies) GDNF, BDNF, IGF-1 (all 10 ng/mL), retinoic
acid (0.1 μM, Sigma Aldrich) pumorphamin (50 ng/mL), cAMP (1 μM,
Sigma Aldrich), neurotrophin 3, 4 (20 ng/mL, Prepotech), vitronectin
(100 ng/mL, Sigma Aldrich), laminin (4 μg/mL), agrin (100 ng/mL) for
3 to 4 weeks, as described elsewhere (Guo et al., 2011, 2013).
In order to facilitate myotube contraction bath temperature was el-
evated to 37 °C (Guo et al., 2011). Electrical ﬁeld stimulation of the
cells was performed with an ELM-2 stimulator. The stimuli, typically
set to 2 V and a duration of 1 ms, were applied at a frequency of
0.5 Hz. Changes of membrane current or voltage were recorded in the
whole-cell recording mode using an EPC-9 ampliﬁer and Patchmaster
software (HEKA, Lambrecht, Germany; (Hamill et al., 1981)). Before re-
cording, the cells were rinsed twicewith an extracellular standard solu-
tion containing (in mM): 140 NaCl, 5 KCl, 1.5 CaCl2, 10 glucose and 12
HEPES; pH 7.3. Patch pipettes were drawn from borosilicate glass with
tip resistances between 3 and 6 MΩwhen ﬁlled with the internal stan-
dard solution (inmM): 140 KCl, 2MgCl2, 4 ATPx2Na, 4 EGTA, 10 HEPES;
pH 7.2. To improve sealing, tips were brieﬂy dipped into 2%
dimethylsilane dissolved in dichloromethane. All patch clamp record-
ings were performed at room temperature.
2.8. Data analysis and statistics
For counting cells in each coverslip (n= 3) 5 representative images
were taken randomly. To quantify myoblasts desmin positive cells and
the total number of cells labelled with DAPI were counted by using
Image J Software (www.imageJ.nih.gov). Then the mean of the desmin
positive/total number of cells ratio was calculated for each experiment
(n = 3). To quantity myotubes the same procedure was used but in
this case actinin positive cells with 2 or more nuclei and showing
some degree of striation were counted.
Expression levels were compared using an un-paired t-test. All sta-
tistical analysis was performed using GraphPad Prism (Version 3.0)
software. Results are represented as mean values ± standard error of
the mean (SEM). Statistical signiﬁcance levels were set to p= 0.05.
2.9. Ethics statement
All animal experiments were performed in compliance with the
guidelines for thewelfare of experimental animals issued by the Federal
Government of Germany, the National Institutes of Health and the Max
Planck Society. The experiments in this study were approved by the
review board of the Land Baden-Württemberg, permit Nr. O.103. All
human material used in this study has been approved by the ethical
committee of Ulm University (Nr. 0148/2009, or 265/12) in compliancewith the guidelines of the federal government of Germany and the Dec-
laration of Helsinki concerning Ethical Principles for Medical Research
Involving Human Subjects.
3. Results
3.1. Protocol for the selection of myogenic progenitors from hiPSC
Our ﬁrst aim was to develop a method to generate hiPSC-derived
myoblasts. In this respect, we established a method to separate myo-
genic progenitors from hiPSCs by CD34 positive selection. In a second
step, we compared myogenic differentiation following the published
protocol using PAX7 overexpression in hiPSCs (Darabi et al., 2012)
andwithmyoblasts generated from amuscle biopsy from a healthy vol-
unteer. A diagram of all 3 procedures is presented in (Fig. 1a–c). For the
CD34-method, EBs were grown adherent. After one week in myogenic
medium, cells migrated out of the EBs and formed a mixed population
containingmesodermal cells (actinin positive cells) but also ectodermal
(tubulin positive) and endodermal cells (β-catenin positive) (Supple-
mental Fig. S1). Thereafter, in order to speciﬁcally select myogenic
progenitors, cellswere immuno-puriﬁed for CD34 and kept inmyogenic
medium supplemented with human conditioned myogenic medium
and FGF-2. In addition, to further purify myogenic precursors, small
cells were gated by size using FACS analysis, plated as single cells and
then further expanded. The mean average of myogenic clones derived
from one single cell was 27.5 ± 7.5%, as assessed by morphology and
further skeletal muscle characterisation described below. In addition,
cultures generated from non-sorted cells were cultivated as cultures
generated from sorted populations. The number of desmin positive
cells was 3.157 ± 0.75% (in hiPSC 1) and therefore further myogenic
expansion was not performed.
3.2. Comparison of myoblast and myotube differentiation protocols
We compared the myogenic cells derived by the three different
methods according to morphological features and markers known to
be characteristic for myoblasts. Myoblasts that developed after CD34
immuno-puriﬁcation were spindle shaped (Fig. 2a) as shown in the
phase contrast images, and were immunopositive against desmin
(Fig. 2a), a marker speciﬁc for early myoblast differentiation (Paulin
and Li, 2004). About 40% of cells were desmin positive from the two
hiPSC cell lines that we originally differentiated into myoblasts (hiPSC
1: 37 ± 7.2%; hiPSC 2: 39 ± 6.3%). These results were quite similar to
myoblasts derived from the primary human myoblast culture, which
also displayed spindle shaped morphology (Fig. 2a). Here, 48 ± 6.3%
of the cells were desmin positive (Fig. 2a). In contrast, myoblasts that
have been differentiated according to the PAX7method became desmin
positive after 4 or more passages (Fig. 2a). An exact quantiﬁcation was
not conducted. PAX7myogenic progenitors, however, also showed typ-
ical myoblast morphology (Fig. 2a). Myoblasts derived by all 3 methods
were also actinin positive (Fig. 2a). We then differentiated myoblasts
from all 3 protocols into myotubes. Following serum deprivation myo-
blasts started to fuse after approximately 7 days (Fig. 2b), and after
2 weeks in differentiation medium multinucleated syncytia formed
(Fig. 2b). Actinin was also strongly expressed in early and mature
myotubes from all 3 methods and showed the typical striatal pattern
in mature ﬁbrers that were differentiated for two weeks (Fig. 2b).
Myotubes containing more than one nucleus, showing some degree of
striation and strongly positive for actinin were also quantiﬁed relative
to the total number of cells. Differentiated cultures form the human pri-
mary cultures and from the CD34 contained a similar percentage of
myotubes (human primary: 26.96 ± 6.989, hiPSC1: 23.96 ± 6.396).
Myoblast from the PAX7 method differentiated more efﬁciently and
presented a higher number of actinin positive-myotubes (58.66 ±
7.499). Next, we analysed a selected set of mRNAs important for the
myogenic lineage (Fig. 2b). Myoblasts generated by the CD34 selection
Fig. 2. A.Myoblast proliferation. Phase contrast micrographs representing proliferatingmyoblasts generated using the threemethods. Myoblasts were round, small cells, proliferated very
rapidly and were desmin and actinin positive. Representative myoblasts are magniﬁed in the inserts. B. Myotube formation. Phase contrast micrographs representing myoblasts from all
threemethods fusing and forming shortmyotubes after 7 days indifferentiationmedium.At 21daysmultinucleatedﬁbres formed (asterisks).Myoblasts generated from the threemethods
were immunostained fort actinin at different stages of differentiation (3 days, 5 days, and 14 days). During differentiation cells fused and formed bi/tri nucleatedmyotubes (asterisks) and
costameres (arrows). 14 days after differentiation typical striatedmultinucleated (asterisks) and fused ﬁbreswere seen. A typical striated pattern labelledwith actinin is shown in themag-
niﬁed inserts. Scale bar: 20 μm. C. Expression markers of myogenic differentiation. Myogenic markers were up-regulated at the mRNA level during myoblast proliferation and differenti-
ation intomyotubes. Unpaired t-test analysis comparing the expression of one geneduringproliferation versusdifferentiation revealed statistical signiﬁcance on the following genes:MYF5,
CHRNA1 (p b 0.001),MYH6,MYOD1,MYOG (all p b 0.001) using the CD34 protocol. For the PAX7 protocol: PAX7,MYF5,MYOG (all p b 0.01),MYH6,MYOD1 (all p b 0.001). The following
genes were up-regulated in myotubes derived from a human biopsy: PAX3, PAX7,MYH6, DES (p b 0.05),MYOG, CHRNA1 (p b 0.01)MYOD1 (p b 0.001). *p b 0.05, **p b 0.001, ***p b 0.001.
DES= DESMIN,MYOG=MYOGENIN.
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contributes to early striated muscle development by playing a critical
role in embryonic muscle formation. The paired box transcription factor
PAX7, an early myogenic marker important for the maintenance of
satellite cells and DESMIN, also an early myogenic marker, were slightly
up-regulated. Following differentiation to myotubes, PAX7 mRNA
expression remained similar. However,MYH6,MYOD1 andMYOGENIN,
markers speciﬁc for early and late myotube differentiation, weresigniﬁcantly up-regulated (Fig. 2d). Myoblasts generated by the PAX7
method expressed – as expected – high levels of PAX7, while DESMIN
was expressed at low levels. When doxycyclin and serum were
removed from the cultures to stop the induction of PAX7 and to force
the cells to fuse and differentiate PAX7mRNAdropped to very low levels
andmarkers of ﬁnal differentiation were expressed (MYH6,MYOD1 and
MYOGENIN) (Fig. 2d). In comparison, biopsy-derived myoblasts
expressed low levels of PAX3, slight PAX7 up-regulation and high
333M. Demestre et al. / Stem Cell Research 15 (2015) 328–336DESMIN levels. Further differentiation of these cells resulted in high
levels of MYH6 and MYOGENIN (Fig. 2d). The mRNA for CHRNA1, the
gene for themuscle speciﬁc AchR-α, was expressed at low levels in pro-
liferating myoblasts and was up-regulated in differentiating myotubes
from all three protocols (Fig. 2d).
3.3. Functional properties of myotubes
The main characteristic of muscles is the ability to contract in re-
sponse to electrical stimulation induced by themotoneuron. To address
this,we cultivatedmyotubes in a serum freemedium containing growth
factors necessary for myotube maturation and contraction (Guo et al.,
2011). Then, we analysed the functionality of myotubes derived from
the three different myogenic cell lines by maintaining the cultures in a
bath at 37 °C. Noneof themyotubes contracted spontaneously, although
myotubes derived from the human biopsy contracted spontaneously
when removed from the incubator, this only lasted a few seconds.
However, by maintaining the cultures at 37 °C and following electrical
ﬁeld stimulation we were able to detect contractions in all 3 lines.
In CD34-hiPSC derived-myotubes 3 weeks after differentiation,
about 4 small long multinucleated ﬁbres per dish contracted rhythmi-
cally upon electrical stimulation (supplemental movie). These cells
displayed resting membrane potentials (mP) from−50 to −70 mV,
were able to generate action potentials and responded to acetylcholine
(Ach) (Fig. 3a,b). In PAX7 hiPSC-generatedmyotubes 1–2 longmultinu-
cleated and striated myotubes per dish were contracting when electri-
cally stimulated. Fibres had a resting membrane potential of −60
to−64mVand also responded to Ach. However, a clear action potential
could only be recorded inmoremature ﬁbres that had been cultured forFig. 3. A. Table. Electrophysiological properties of myotubes in culture after differentiation. B. R
tential following acetylcholine treatment. Abbreviations: mP = resting membrane potential, Amore than 4weeks in the differentiationmedium (supplementalmovie,
Fig. 3a,b). Following electrical stimulation, myotubes derived from a
human muscle biopsy presented contractions. This was observed in
about 5 ﬁbres per dish (supplemental movie). These ﬁbres exhibited a
resting membrane potential from −55 to −73 mV, showed action
potentials and responded to Ach (Fig. 3a,b). This data provides further
indications of the high level of maturation of our cultured hiPSC derived
myotubes at the functional level.
3.4. Neuromuscular junction formation between hiPSC-derivedmotoneurons
and hiPSC derived myotubes
A key characteristic of myotubes and muscle ﬁbres is the ability to
connect with motoneurons via neuromuscular endplates. Since we
had demonstrated that our cultures respond to Ach, a key molecule
that binds to the AchR present in themuscle opening ligand gated sodi-
um channels; and sequentially initiatingdifferent steps to producemus-
cle contraction in vivo. We ﬁrst examined myotubes using antibodies
directed against the AChR-α that is solely localised in skeletal muscle
cells. Myotubes generated using the CD34- or PAX7 methods as well
as from the human biopsy showed AChR-α staining in clusters along
the ﬁbres (Fig. 4a). These cells were also positive for two speciﬁc
myotube markers, myosin heavy chain (Fig. 4a) and actinin (Fig. 4a).
In co-cultures of hiPSC derived motoneurons and hiPSC CD34-derived
myotubes after 1 day neurites deriving from the motoneuron-spheres
started to grow out from the motoneuron-spheres seeking contact
with the myotubes (Fig. 4b). Two weeks later, outgrowing neurites
made contacts with myotubes (Fig. 4b) as shown in the phase contrast
images. At this stageα-BT AchR-α formed big clusters (Fig. 4c) but fullyepresentative traces of current-clamp measurements and the generation of and action po-
P = action potential.
Fig. 4. A. Myotube characterisation. Myotubes differentiated for 21 days derived from all three methods (CD34, PAX7 and human muscle biopsy) were triple immunolabelled for MHC,
actinin and AchR-α. B. Neurite extension during co-cultivation. Representative phase contrast images of a hiPSC derived moto-neurosphere 1 day after plating. Small neurites were out
growing from the moto-neurosphere. After 14 and 21 days neurites made contacts with myotubes. Representative areas are shown in the inserts. C. Aggregation of AchR clusters.
hiPSC-derived motoneurons were co-cultured with CD34-enrichment derived myotubes. 14 days after co-cultivation AchR clusters labelled with α-BT were detected. Scale bar: 20 μm,
MHC = myosin heavy chain, AchR = acetylcholine receptor, BT = bungarotoxin. NF = neuroﬁlament heavy chain.
334 M. Demestre et al. / Stem Cell Research 15 (2015) 328–336mature NMJ were still not fully developed. After 21 days numerous
nerve–muscle contacts were established (Fig. 5a) and AchR formed
mature NMJs as shown by the typical curvy morphology labelled with
α-BT, and tubulin positive neurons could be shown to make contacts
with the end plate (Fig. 5a). Similarly, co-cultures were labelled with
the pre-synaptic marker Bassoon that labels synaptic contacts along
axons labelled with neuroﬁlament (NF) (Fig. 5b, top). At the end plate
area NF positive axons were in close apposition with α-BT labelledNMJ. In the same area small punctae stained with Bassoon were also
detected, indicating pre and post-synaptic contacts (Fig. 5b, bottom).
Similarly, myotubes generated with the PAX7 method were
co-cultured with hiPSC derived motoneurons for one and 3 weeks.
Again, AchR formed typical clusters labelled with α-BT in early motor
end plate formation and displaying a typical NMJmorphology inmature
cultures, and tubulin positive neurons established contacts withmature
end plates (Supplemental Fig. S2a,b).
Fig. 5. A.Maturation of AchR clusters and NMJ formation. hiPSC-derivedmotoneurons were co-culturedwith CD34-enrichment derivedmyotubes. After 21 days of co-cultivation the for-
mation ofmature end plates was observed byα-BT labelling. B. Formation of synaptic boutons and pre and post-synaptic appositions at the end plate. After 21 days in co-culture pre-syn-
aptic terminals labelledwith Bassoonwere strongly detected along the axons (topﬁgure). At the endplate region a close apposition between pre-synaptic and post-synapticmarkers could
be detected, as shown by Bassoon andα-BT stainings (bottom ﬁgure). Scale bar: 20 μm, AchR= acetylcholine receptor, BT= bungarotoxin. NF=neuroﬁlament heavy chain. Inserts rep-
resent magniﬁed areas at ×200.
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form end plates by using a human-rat hybrid co-culturing system with
hiPSCmyotubes and primarymotoneurons isolated from rat embryonic
tissue. After two weeks end-plates stained for α-BT were formed that
have been induced by neurons positive for tubulin. Muscle cells
were stained with antibodies directed against actinin (Supplemental
Fig. S2c).
4. Discussion
In the present study, we show that a NMJ model can be established
using different methods to derive myotubes from myogenic lineage
precursor cells including CD34+ based enrichment. Moreover, we
established a protocol to create a motor unit (motoneuron and
contacting muscle cells) both derived from the same hiPSC line as a
novel in vitro read out system.
Generating myoblast cultures from primary skeletal muscle tissue
after a muscle biopsy is a well-established technique (Malatesta et al.,
2013). However, access to biopsy-derived skeletal muscle to set up
myoblast cultures is often restricted and the analysis of NMJs limited.
In contrast, access to tissues from which hiPSc can be set up, such as
hair-root cells, is simple, since this is a non-invasive procedure and
ethical permission is more easily to be obtained. In addition, hiPSCs
have successfully been differentiated into many different cell types,
such as motoneurons, pancreatic cells and Schwann cells (Bilic and
Izpisua Belmonte, 2012). In particular, we have previously shown that
motoneurons can be derived reliably (Stockmann et al., 2011). For the
formation of NMJsmotoneurons need to liaisewithmyoﬁbers. To estab-
lish amodel for the NMJ from hiPSc generated from the same individual
we therefore next derived skeletal muscle cells in two ways. First, weused a CD34+ enrichment method in which cells outgrowing from
EBs were selected for CD34, a marker expressed by satellite cells
(Jankowski et al., 2002). Secondly, we used a protocol over-expressing
the myogenic factor PAX7 to force myogenic differentiation (Darabi
et al., 2012; Tanaka et al., 2013; Abujarour et al., 2014).
After CD34+ enrichment myoblast generation was achieved by cell
selection and consecutive culture under speciﬁc myogenic conditions.
This resulted in cultures that closely reﬂected the morphology and
expression proﬁle of cells of the early myo-lineage of primary cultures
with low expression of PAX7, and desmin and actinin localisation in
myoblasts. Finally, we differentiated myoblasts into myotubes and
assessed their morphological and functional features. Using either
method (CD34 or PAX7), or primary myoblasts, we could identify mul-
tinucleated striated myotubes. Myotubes expressed actinin and MHC
together withMYOD1 and MYOGENINmRNA, had a resting membrane
potential and contracted following electrical stimulation. Myotubes
derived by the three methods expressed the muscle speciﬁc AchR and
generated action potentials in response to Ach indicating the binding
of Ach to the speciﬁc AchR and the depolarisation of myotube mem-
branes. However, myotubes generated by PAX7 induction took longer
to mature and be able to generate an action potential, and only a few
contracting ﬁbres were observed.
Since the analysis of a completemotor unit is essential for the under-
standing of pathophysiological mechanisms of motoneuron diseases
(Moloney et al., 2014), or conditions involving the NMJ, we established
an in vitro model of motor units. To that end, we cultivated hiPSC cell
lines from healthy control subjects and differentiated hiPSCs from the
same cell line into motoneurons and myotubes. Subsequently, we co-
cultivated these two cell types together in vitro. In theﬁrstweek clusters
of AchRs appeared, and early outgrowing neurites from motoneurons
336 M. Demestre et al. / Stem Cell Research 15 (2015) 328–336became visible in close vicinity of future end plate regions. At 3weeks of
co-cultivation motoneurons seemed to actively induce the maturation
of muscle cells and strong AChR aggregation. Finally, NMJs could readily
be detected.
5. Conclusions
We report on a model of the NMJ derived from the same parental
hiPS cell line. This model should be very useful in motor unit research
in health and disease. For instance, the model will help to investigate
the effects of speciﬁc neurodegenerative mutations on the morphology
and physiology of NMJs. The co-culturing of affected motoneurons with
control muscle cells and vice versawill for example help to decipher the
role of both cell types for the motoneuron disease pathogenesis.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2015.07.005.
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